Paget disease manifesting with compressive sixth-nerve palsy that resolved with intravenous zoledronic acid therapy [1]

Archives of Ophthalmology

Volumn 125, Issue 10, 2007, Pages 1440-1441

  Pane, Anthony ^a  

^a QUEENSLAND EYE INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ZOLEDRONIC ACID;

AGED; CASE REPORT; CLINICAL FEATURE; EYE DISEASE; FACE PAIN; FACIAL NERVE PARALYSIS; HUMAN; LETTER; MALE; NERVE PARALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PAGET DISEASE; PARESTHESIA; PRIORITY JOURNAL;

ABDUCENS NERVE DISEASES; AGED; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; DIPLOPIA; HUMANS; IMIDAZOLES; INFUSIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; NERVE COMPRESSION SYNDROMES; OSTEITIS DEFORMANS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 35348952672     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.125.10.1440     Document Type: Letter

References (4)

1. Schneider D, Hofmann MT, Peterson JA. Diagnosis and treatment of Paget's disease of bone. Am Fam Physician. 2002;65(10):2069-2072.
2. Poncelet A. The neurologic complications of Paget's disease. J Bone Miner Res. 1999;14(suppl 2):88-91.
3. Siris ES, Lyles KW, Singer FR, Meunier PJ. Medical management of Paget's disease of bone: indications for treatment and review of current therapies. J Bone Miner Res. 2006;21(suppl 2):P94-P98.
4. Keating GM, Scott LJ. Zoledronic acid: a review of its use in the treatment of Paget's disease of bone. Drugs. 2007;67(5):793-804.